JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
LPNT
3051
DELISTED
LifePoint Health, Inc.
LPNT
| $2.45M | ﹤0.01% |
49,133
-83,456
| -63% | -$4.15M |
2014 Q2
14 quarters
|
|
3052
WisdomTree Emerging Markets High Dividend Fund
DEM
$4.14B
| $2.44M | ﹤0.01% |
53,857
+15,068
| +39% | +$658K |
2013 Q2
18 quarters
|
|
3053
Marcus Corp
MCS
$837M
| $2.44M | ﹤0.01% |
89,182
-15,923
| -15% | -$439K |
2016 Q1
7 quarters
|
|
|
QIWI
3054
DELISTED
QIWI PLC
QIWI
| $2.44M | ﹤0.01% |
140,619
-250,299
| -64% | -$4M |
2014 Q1
15 quarters
|
|
|
RSO
3055
DELISTED
Resource Capital Corp.
RSO
| $2.43M | ﹤0.01% |
259,812
-17,246
| -6% | -$173K |
2013 Q2
18 quarters
|
|
3056
Paylocity
PCTY
$7.76B
| $2.43M | ﹤0.01% |
51,496
+51,236
| +19,706% | +$2.48M |
2015 Q4
8 quarters
|
|
3057
NovoCure
NVCR
$1.78B
| $2.43M | ﹤0.01% |
+120,174
| New | +$2.31M |
2017 Q4
0 quarters
|
|
3058
PUT
Axalta
AXTA
$6.87B
| $2.43M | ﹤0.01% |
+75,000
| New | +$2.38M |
2017 Q4
0 quarters
|
|
|
CBI
3059
PUT
DELISTED
Chicago Bridge & Iron Nv
CBI
| $2.42M | ﹤0.01% |
150,000
| – | – |
2017 Q1
3 quarters
|
|
|
CWBC
3060
Community West Bancshares
CWBC
$717M
| $2.42M | ﹤0.01% |
119,944
-8,978
| -7% | -$184K |
2016 Q2
6 quarters
|
|
3061
PUT
American Eagle Outfitters
AEO
$2.97B
| $2.4M | ﹤0.01% |
+127,900
| New | +$1.93M |
2017 Q4
0 quarters
|
|
3062
West Bancorporation
WTBA
$506M
| $2.4M | ﹤0.01% |
95,592
-373
| -0.4% | -$9.42K |
2013 Q2
18 quarters
|
|
|
PKD
3063
DELISTED
Parker Drilling Company
PKD
| $2.4M | ﹤0.01% |
159,732
-7,231
| -4% | -$112K |
2013 Q2
18 quarters
|
|
|
EVRI
3064
DELISTED
Everi Holdings
EVRI
| $2.39M | ﹤0.01% |
317,359
+59,459
| +23% | +$479K |
2017 Q1
3 quarters
|
|
3065
Viavi Solutions
VIAV
$11.7B
| $2.39M | ﹤0.01% |
273,757
+80,855
| +42% | +$732K |
2013 Q2
18 quarters
|
|
3066
Interparfums
IPAR
$3.61B
| $2.39M | ﹤0.01% |
55,041
+10,800
| +24% | +$470K |
2013 Q2
18 quarters
|
|
|
LMNX
3067
DELISTED
Luminex Corp
LMNX
| $2.38M | ﹤0.01% |
121,123
+93,140
| +333% | +$1.94M |
2015 Q4
8 quarters
|
|
|
RDUS
3068
CALL
DELISTED
Radius Health, Inc.
RDUS
| $2.38M | ﹤0.01% |
+75,000
| New | +$2.35M |
2017 Q4
0 quarters
|
|
|
RDUS
3069
PUT
DELISTED
Radius Health, Inc.
RDUS
| $2.38M | ﹤0.01% |
+75,000
| New | +$2.35M |
2017 Q4
0 quarters
|
|
3070
IDT Corp
IDT
$1.96B
| $2.38M | ﹤0.01% |
265,250
-367,256
| -58% | -$4.02M |
2013 Q2
18 quarters
|
|
|
BMTC
3071
DELISTED
Bryn Mawr Bank Corp
BMTC
| $2.38M | ﹤0.01% |
53,763
+1,938
| +4% | +$85.6K |
2016 Q2
6 quarters
|
|
3072
Aaon
AAON
$6.95B
| $2.37M | ﹤0.01% |
96,900
+15,766
| +19% | +$370K |
2017 Q3
1 quarter
|
|
|
HDP
3073
DELISTED
Hortonworks, Inc.
HDP
| $2.37M | ﹤0.01% |
117,849
+115,018
| +4,063% | +$2.11M |
2016 Q4
4 quarters
|
|
3074
Boot Barn
BOOT
$3.67B
| $2.37M | ﹤0.01% |
142,500
+132,387
| +1,309% | +$1.59M |
2016 Q4
4 quarters
|
|
3075
State Street SPDR S&P Global Dividend ETF
WDIV
$276M
| $2.36M | ﹤0.01% |
33,370
+1,721
| +5% | +$119K |
2014 Q3
13 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.